WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 19 fonti

Scientists target human trials for new Ebola vaccine 'within months'

This funding surge aims to fast-track vaccine candidates against the deadly Ebola Bundibugyo strain.

Raccontata dathecitizen.co.tzmorningstar.comindependent.co.ukit.euronews.comeuronews.comqz.comthenationalnews.comg4media.rokoreatimes.co.krsueddeutsche.devanguardngr.comlecho.be+7 altre

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
nation.africaStai leggendo6 h fa

Scientists target human trials for new Ebola vaccine 'within months'

This funding surge aims to fast-track vaccine candidates against the deadly Ebola Bundibugyo strain.

originale
arabnews.com18 h fa

Moderna and other groups get $60m to develop Ebola vaccine

CEPI funds Moderna, Oxford, IAVI with $60M for Ebola Bundibugyo trials in two months, addressing 282+ DRC cases. mRNA platform reuse compresses vaccine cycles from years to months—a governance model for infrastructure agility under crisis.

Leggi questa versione → originale
businessday.ng5 h fa

Race for Ebola vaccine gets $60m boost - Businessday NG

Global health organisation CEPI will give roughly $60 million to Moderna and two other groups to accelerate the development of shots...

Leggi questa versione → originale
thejakartapost.com9 h fa

Moderna and other groups get $60 million to develop Ebola vaccine - Middle East and Africa - The Jakarta Post

CEPI allocated $60M to Moderna and partners for rapid Ebola Bundibugyo vaccine development with trials within months. The pace tests pandemic-era platform scalability while revealing manufacturing and trial logistics as the critical constraint for emergency response deployment.

Leggi questa versione → originale
euronews.com1 g fa

Health body fast-tracks three Ebola vaccines as virus continues spread

Global health body CEPI is fast-tracking three experimental vaccines against the Bundibugyo strain of Ebola as the outbreak in Central Africa continues to spread.

Leggi questa versione → originale
arstechnica.com15 h fa

Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo

Amid a raging Ebola outbreak, officials "urgently accelerate development" of vaccines.

Leggi questa versione → originale

Timeline cronologica

  1. sabato 30 maggio 2026·thecitizen.co.tz

    Funding pledges for Ebola outbreak almost halved, Africa CDC says

    Director-General Jean Kaseya told a virtual press conference that Africa CDC's ⁠partners on Monday had pledged almost $500 million to support the fight against the outbreak.

  2. lunedì 1 giugno 2026·morningstar.com

    Moderna and CEPI Expand Strategic Collaboration to Advance Potential Vaccine Against Bundibugyo Ebolavirus

    Coalition for Epidemic Preparedness Innovationsfunding builds on Moderna's prior filovirus research and supports preclinical development and Phase 1 clinical evaluation CAMBRIDGE,…

  3. lunedì 1 giugno 2026·independent.co.uk

    Moderna receives $50 million to develop Ebola vaccine as number of cases surge

    This initiative is crucial as health authorities worldwide race to identify medical options and contain the outbreak, which has seen over 900 suspected cases and more than 220…

  4. lunedì 1 giugno 2026·it.euronews.com

    Autorità sanitaria accelera tre vaccini anti Ebola in piena diffusione

    L’ente globale per la salute CEPI sta accelerando lo sviluppo di tre vaccini sperimentali contro il ceppo Bundibugyo dell’Ebola, mentre il focolaio in Africa centrale continua a…

  5. lunedì 1 giugno 2026·euronews.com

    Health body fast-tracks three Ebola vaccines as virus continues spread

    Global health body CEPI is fast-tracking three experimental vaccines against the Bundibugyo strain of Ebola as the outbreak in Central Africa continues to spread.

  6. lunedì 1 giugno 2026·it.euronews.com

    Autorità sanitaria accelera tre vaccini anti Ebola

    L’ente globale per la salute CEPI sta accelerando lo sviluppo di vaccini sperimentali contro il ceppo Bundibugyo dell’Ebola. Il focolaio in Africa centrale continua a propagarsi

  7. lunedì 1 giugno 2026·qz.com

    Moderna partners with CEPI on Bundibugyo Ebola vaccine

    CEPI is committing up to $50 million to support Moderna's vaccine candidate for the strain with no approved shot

  8. lunedì 1 giugno 2026·thenationalnews.com

    Race for Ebola vaccine gets $50m boost as medics struggle to trace contacts | The National

    Four nurses discharged from DR Congo hospital after recovering from virus

  9. lunedì 1 giugno 2026·g4media.ro

    Trei noi vaccinuri experimentale pentru virusul Ebola vor fi finanțate de Coaliția pentru Inovații în domeniul Pregătirii pentru Epidemii

    Coaliția pentru Inovații în domeniul Pregătirii pentru Epidemii (CEPI) va „accelera de urgență” dezvoltarea a trei vaccinuri experimentale împotriva virusului Bundibugyo,…

  10. lunedì 1 giugno 2026·koreatimes.co.kr

    Moderna and other groups get $60 million to develop Ebola vaccine - The Korea Times

    Global health organisation CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebo...

  11. lunedì 1 giugno 2026·sueddeutsche.de

    Moderna entwickelt Impfstoff gegen Ebola-Variante

    Der US-Pharmakonzern will mit Unterstützung der internationalen Impfallianz CEPI einen Impfstoff gegen das Bundibugyo-Ebolavirus herstellen. Diese Ebola-Variante verbreitet sich…

  12. lunedì 1 giugno 2026·vanguardngr.com

    'We need to act now': Race to develop Ebola vaccine heats up

    While it marks the 17th Ebola outbreak in the DRC, it is just the third caused by the Bundibugyo strain, for which there are no...

  13. lunedì 1 giugno 2026·lecho.be

    60 millions de dollars débloqués pour accélérer la mise au point d’un vaccin contre Ebola

    Alors que l’épidémie d’Ebola Bundibugyo continue de progresser en République démocratique du Congo et en Ouganda, plusieurs organisations internationales débloquent des dizaines…

  14. lunedì 1 giugno 2026·arabnews.com

    Moderna and other groups get $60m to develop Ebola vaccine

    BENGALURU: Global health organization CEPI will give roughly $60 ​million to Moderna and to two other groups to accelerate the development of shots against Ebola Bundibugyo, the…

  15. lunedì 1 giugno 2026·channel4.com

    Ebola: $62 million pledge to speed up vaccine development

    A global body set up to accelerate the development of vaccines has pledged $62 million to speed up progress on experimental jabs aimed at tackling the virus behind the Ebola…

  16. lunedì 1 giugno 2026·arstechnica.com

    Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo

    Amid a raging Ebola outbreak, officials "urgently accelerate development" of vaccines.

  17. lunedì 1 giugno 2026·statnews.com

    Global coalition to fast-track three vaccines targeting Ebola outbreak with $62 million in funding

    With no licensed vaccines available to protect against the Ebola virus currently spreading in the Congo, efforts are underway to fast-track development of at least three vaccines.

  18. martedì 2 giugno 2026·valor.globo.com

    Três grupos recebem US$ 60 milhões para desenvolver vacina contra ebola

    Moderna, Serum Institute of India com Universidade de Oxford, e coalizão mundial para vacina contra Aids Iavi ganham fundos; Moderna recebe US$ 50 milhões

  19. martedì 2 giugno 2026·thejakartapost.com

    Moderna and other groups get $60 million to develop Ebola vaccine - Middle East and Africa - The Jakarta Post

    The Coalition for Epidemic Preparedness Innovations was one of the early investors that helped to develop a vaccine at the height of the COVID-19 pandemic.

  20. martedì 2 giugno 2026·economictimes.indiatimes.com

    Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI funding

    Serum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fresh funding to combat a spreading outbreak…